Palm Beach, Florida-based 1789, which seeks to invest in conservative-leaning companies, is leading the $140 million round, which values BlinkRx at roughly $2 billion, said the people, who asked not to be identified discussing confidential information.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.